These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 20231582)

  • 1. The case for C-reactive protein as a risk marker for coronary heart disease.
    Cook NR
    Ann Intern Med; 2010 Mar; 152(6):406; author reply 406-7. PubMed ID: 20231582
    [No Abstract]   [Full Text] [Related]  

  • 2. The USPSTF recommendation statement on coronary heart disease risk assessment.
    Glynn RJ
    Ann Intern Med; 2010 Mar; 152(6):403; author reply 405-6. PubMed ID: 20231577
    [No Abstract]   [Full Text] [Related]  

  • 3. The USPSTF recommendation statement on coronary heart disease risk assessment.
    Blaha MJ; Campbell CY; Horne A
    Ann Intern Med; 2010 Mar; 152(6):404-5; author reply 405-6. PubMed ID: 20231578
    [No Abstract]   [Full Text] [Related]  

  • 4. The USPSTF recommendation statement on coronary heart disease risk assessment.
    Budoff MJ
    Ann Intern Med; 2010 Mar; 152(6):403-4; author reply 405-6. PubMed ID: 20231576
    [No Abstract]   [Full Text] [Related]  

  • 5. The USPSTF recommendation statement on coronary heart disease risk assessment.
    Matteson EL; Crowson CS; Gabriel SE
    Ann Intern Med; 2010 Mar; 152(6):405; author reply 405-6. PubMed ID: 20231580
    [No Abstract]   [Full Text] [Related]  

  • 6. [C-reactive protein in coronary disease--pathogenic factor or marker of the disease].
    Goch JH; Sadurska J
    Pol Merkur Lekarski; 2002 Jul; 13(73):70-3. PubMed ID: 12362513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should high sensitive C-reactive protein measurement be included in health screening packages?
    Hawkins RC; Leong L
    Singapore Med J; 2006 Oct; 47(10):837-40. PubMed ID: 16990957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk stratification in stable coronary artery disease: superiority of N-terminal pro B-type natriuretic peptide over high-sensitivity C-reactive protein, gamma-glutamyl transferase, and traditional risk factors.
    Bode E; Wuppinger T; Bode T; Alber H; Ulmer H; Pachinger O; Mair J
    Coron Artery Dis; 2012 Mar; 23(2):91-7. PubMed ID: 22157356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-reactive protein and atherosclerosis: quo vadis?
    Koenig W; Torzewski J
    Ital Heart J; 2001 Nov; 2(11):801-3. PubMed ID: 11770861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-reactive protein for risk assessment in coronary artery disease.
    Danchin N
    Heart; 2010 Mar; 96(5):325-7. PubMed ID: 19933748
    [No Abstract]   [Full Text] [Related]  

  • 11. After menopause: novel marker helps to identify women at risk for heart disease.
    Lewis SL
    J Fam Pract; 2004 Jul; Suppl():S18-24. PubMed ID: 15251109
    [No Abstract]   [Full Text] [Related]  

  • 12. Risk marker may play key role in heart disease.
    Health News; 2005 Mar; 11(3):2. PubMed ID: 15803566
    [No Abstract]   [Full Text] [Related]  

  • 13. Mayo Clinic office visit. Testing C-reactive protein. An interview with Thomas Behrenbeck, M.D., Ph.D.
    Behrenbeck T
    Mayo Clin Womens Healthsource; 2010 Feb; 14(2):6. PubMed ID: 20048728
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum levels of C-reactive protein in patients with stable coronary artery disease: JUPITER in perspective.
    Saely CH; Rein P; Vonbank A; Drexel H
    Int J Cardiol; 2010 Oct; 144(3):448-9. PubMed ID: 19351576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value of homocysteine, C-reactive protein and bilirubin for coronary artery disease.
    Yilmaz N; Ciçek HK; Celik A; Meram I; Kocabas R; Davutoglu V
    East Mediterr Health J; 2007; 13(3):522-35. PubMed ID: 17687824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-reactive protein--marker for atherothrombotic events.
    Gogna A; Sinha RS; Gupta B
    J Assoc Physicians India; 1999 Aug; 47(8):818-20. PubMed ID: 10778631
    [No Abstract]   [Full Text] [Related]  

  • 17. C reactive protein--marker for atherothrombotic events.
    Gogna A; Sinha RS; Gupta B
    J Assoc Physicians India; 1999 Jun; 47(6):631-3. PubMed ID: 10999165
    [No Abstract]   [Full Text] [Related]  

  • 18. The time for cardiovascular inflammation reduction trials has arrived: how low to go for hsCRP?
    Ridker PM
    Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1222-4. PubMed ID: 18565847
    [No Abstract]   [Full Text] [Related]  

  • 19. Beyond C-reactive protein; new evidence for another inflammatory biomarker predicting cardiovascular disease risk.
    Kajinami K; Kawai Y
    Atherosclerosis; 2011 Jan; 214(1):39-40. PubMed ID: 21036356
    [No Abstract]   [Full Text] [Related]  

  • 20. [C-reactive protein in patients with coronary heart disease].
    Rajtar R; Kolasińska-Kloch W; Kloch M
    Folia Med Cracov; 2004; 45(1-2):25-32. PubMed ID: 16276823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.